Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder
NCT07566104Phase 2Not yet recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2027
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in major depressive disorder (MDD), sponsored by University of California, Los Angeles. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
psilocybin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07566104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07566104.